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Abstract
Background The objective of this study was to establish age-
dependent values for urinary renalase/creatinine (renalase/Cr)
ratio in healthy children and adolescents.
Methods The study was conducted on a random sample of
157 healthy children and adolescents (0.1–17.9 years) divided
into six age groups in 3-year intervals. Urine renalase concen-
tration was measured using an enzyme-linked immunosorbent
assay (ELISA) kit (Uscn Life Science, Wuhan, China).
Results We analyzed median urine renalase/Cr ratio in partic-
ular age groups with the use of analysis of variance (ANOVA).
Renalase/Cr levels were significantly higher in the youngest
children < 3 years in comparison with other age groups
(4.07 ng/mg Cr, p<0.05). There was a statistically significant
negative correlation between urine renalase/Cr and body mass
index (BMI) Z-score (r=−0.22, p<0.05) and both systolic
(r=−0.22, p<0.05) and diastolic (r=−0.21, p<0.05) blood
pressure. We constructed the reference renalase/Cr percentiles
according to age in 3-year intervals.
Conclusions To the best of our knowledge, this study is the
first to present reference values of urine renalase excretion in a
healthy pediatric population. Further studies should concen-
trate on the influence of increased blood pressure or obesity on
urine renalase excretion in children and teenagers.
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Introduction
Renalase is a flavin adenine dinucleotide-dependent (FAD-
dependent) hormone belonging to the amino-oxidase family
that was recently identified by Xu et al. [1]. It is secreted into
the blood by the kidney but is also found in heart, skeletal
muscles, small intestine, and liver. Renalase can be easily
detected in plasma or urine by Western blotting. In the circu-
lation, it resides as a 32-kDa monomer, whereas in urine, in
addition to the band of expected size, second, larger doublet
(65–75 kDa) has been detected, which can be a result of
aggregation or dimerization of the typical monomeric form
[1, 2]. Detection of renalase in blood and urine suggests its
production by renal tissue, and undetectable levels of the
enzyme in the plasma of patients with uremia confirm this
hypothesis [1, 2]. Renalase metabolizes circulating catechol-
amines and thus regulates blood pressure (BP) and sympa-
thetic tone [3, 4]. In vivo observations show that renalase
occurs in blood as a precursor and is activated by increased
catecholamines levels. Its strongest enzymatic activity is to-
ward dopamine, adrenaline, and noradrenaline [5]. Renalase
levels are studied in clinical cardiology and nephrology. Nor-
mal values are essential for interpretation of results, especially
in pediatric patients. Analysis in our study aimed to establish
reference values and upper limits for children and teenagers.
Despite many studies in adults, there are still no data
concerning serum or urine renalase concentration in the pedi-
atric population. The aim of this study was to establish age-
dependent values for urinary renalase concentration in healthy
children and adolescents.
Participants and methods
The study was conducted on a random sample of 157 healthy
children and adolescents (78 boys; 79 girls) aged 8.5 (0.1–
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17.9) years. Materials and data were obtained from partici-
pants in the (OLAF) study and from healthy children of
hospital staff members. Informed consent was obtained from
parents of all participants and from children > 16 years of age.
The study protocol was approved by Local Committee of
Bioethics, Medical University of Bialystok, while the OLAF
study was approved by the Children’s Memorial Health Insti-
tute Ethics Committee. Past and present medical history was
taken from parents. Body weight and height were measured
using a balance-beam scale and pediatric wall-mounted
stadiometer; body mass index (BMI) was calculated as weight
(in kilograms) divided by the square of height (meters
squared). Age-specific reference values for BMI were gener-
ated by the lambda, mu, sigma method (LMS) method [6].
LMS values were taken from the OLAF study published by
Kulaga et al. [7]. Blood pressure was measured using a vali-
dated oscillometric device (Datascope Accutor Plus) with the
participant in a sitting position. Three measurements were
taken in 3-min intervals, and the arithmetical average was
used for statistical analysis. Anthropometric methods have
been described thoroughly in OLAF study publications [8,
9]. BMI values are expressed as Z-scores. Inclusion criteria
were healthy children and adolescents aged 0.1–18 years.
Exclusion criteria were any signs of infection, chronic dis-
eases, and medications that influence renal function or inter-
fere with BP values.
After an overnight fast, first morning-voided urine
samples were collected, transported to the laboratory with-
in 4 h, and frozen at −80 °C. Urine renalase concentration was
measured using the enzyme-linked immunosorbent assay
(ELISA) kit (Uscn Life Science, Wuhan, China) according
to manufacturer’ instructions and expressed as renalase/
creatinine ratio (renalase/Cr) in ng/mg creatinine. Mean
intra- and interassay coefficients of variation for renalase were
CV <10 % and CV <12 %, respectively. The detection limit
was 3.12–200 ng/ml.
Data were analyzed with Statistica program (version 10.0,
StatSoft, Tulsa, OK, USA), and the Kolmogorov–Smirnov
test was used to determine normality of variables. Discrete
variables were expressed as counts (percentage) and continu-
ous variables as median and quartiles, unless stated otherwise.
The comparison between the two groups was done using
chi-square and Fisher exact tests for categorical variables
and t test for continuous variables for normally distribut-
ed data, or Mann–Whitney or analysis of variance
;(ANOVA) tests for nonnormally distributed data. Corre-
lations between urine renalase/Cr and other variables
were evaluated by Pearson’s or Spearman’s test, as ap-
propriate, in both groups. P<0.05 was considered statis-
tically significant. Age-specific reference values for
renalase/Cr ratio were generated by LMS [10] using
LMSChartMaker software, which characterizes the distri-
bution of a variable by its median, CV, and skewness (L)
required to transform data to normality [11]. Centile
curves for age were obtained as:
C100α tð Þ ¼ M tð Þ 1þ L tð ÞS tð ÞZα½ 1=L tð Þ
where Zα is the normal equivalent deviate for tail area α, and
C100α (t) is the centile corresponding to Zα.
Results
The study group of 157 individuals was divided into six age
groups in 3-year intervals: 0.1–2.9, 3–5.9, 6–8.9, 9–11.9, 12–
14.9, and 15–18 years old; 50.3 % were and 49.7 % boys of
similar age (p>0.05). There were no statistically significant
differences in BMI, BMI Z-scores, and systolic (sBP) or
diastolic (dBP) BP measurements between girls and boys
(p>0.05). Median values of renalase/Cr were similar in both
groups (p>0.05). Group characteristics are shown in Table 1.
We observed statistically significant negative correlation
between urine renalase/Cr and age (r=−0.16, p<0.05). There-
fore, we assessed urine renalase/Cr in particular age groups in
3-year intervals. The highest values were found in the youn-
gest children (0.1–2.9 years), and we observed a decrease in
renalase urine concentration with age. Statistically significant
difference between the youngest group and all other groups
was found. Additionally, significant increase in urine renalase/
Cr was found in children aged 9–11.9 years. Figure 1 presents
statistically significant differences in median concentration
of urine renalase/Cr in particular age groups (ANOVA,
p<0.05) The highest levels were in children <3 years
(407 ng/mg Cr) and the lowest in the oldest children >15 years
(136 ng/mg Cr).
Reference percentiles for renalase/Cr without stratification
for gender were constructed in 3-year intervals without skew-
ness. The Box–Cox power transformations L for height were
set to 1 at all age groups. Renalase/Cr edf parameters were
L3M5S3. Results are given in Table 2.
Table 1 Characteristic of study participants
Variable Female N=79 Male N=78 P value
Median (Q1, Q3) Median (Q1,Q3)
Age (years) 8 (5.5–10.9) 8.85 (5–12.2) NS
BMI 17.31 (14.99–21.3) 18.46 (16.37–21.08) NS
BMI Z-score 0.1 (−1.02–1.52) 0.62 (0.18–1.51) NS
Urine renalase/Cr
(ng/mg Cr)
160 (89–385) 246 (110–430) NS
sBP (mmHg) 108 (103–115) 108 (102–119) NS
dBP (mmHg) 63 (58–70) 65 (60–68) NS
BMI body mass index, Cr creatinine, sBP systolic blood pressure, dBP
diastolic blood pressure, Q quartile, NS not significant
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We also assessed the potential relationship between urine
renalase/Cr and parameters of physical development and BP
values. There was a significantly negative correlation between
urine renalase/Cr and BMI Z-score (r=−0.22, p<0.05) and
both systolic and diastolic BP (r=−0.22, p<0.05 and r=−0.21,
p<0.05, respectively) (Fig. 2).
Discussion
This study provides normative ranges of urine renalase/Cr in
designated age groups in a pediatric population. Overall, mean
participant agewas 8.52±4.76 years, and the sample was nearly
equally divided between boys and girls. Differences in patterns
of urine renalase levels were not found based on gender. There
was a significant negative correlation between renalase/Cr and
age, with levels being higher in the youngest children. In
reviewing the literature, no data was found on the association
between urine renalase excretion and age in the pediatric pop-
ulation; however, there are studies concerning catecholamine
evaluation in healthy children and adolescents. Nunez et al.
revealed significant age-related differences in urine concentra-
tion of dopamine, adrenaline, and noradrenaline [12]. The
highest catecholamine levels were observed in children <
2 years old. Li et al. [5] reported that renalase could be activated
and secreted into the blood by infusion of catecholamines and/
or a transient increase in BP. When renalase was activated, it
degraded plasma catecholamines and thus caused a significant
drop in BP [5]. Since renalase circulates as a proenzyme and an
increase in catecholamine concentrations is an activating trig-
ger, it seems obvious that higher concentrations of dopamine,
adrenaline, and noradrenaline may explain elevated renalase
levels. Surprisingly, we also found increases in urine renalase/
Cr in children aged 9–11.9 years. It seems possible that these





























Fig. 1 Comparison of urine
renalase/creatinine ratio between
six age groups (analysis of
variance chi square=11.19,
p<0.05). Age groups:
a 0.1–2.9 years, b 3–5.9 years,
c 6–8.9 years, d 9–11.9 years,
e 12–14.9 years, f 15–17.9 years
Table 2 Urine renalase/creatinine ratio reference values by age intervals (ng/mg)
Edf: Centiles (urine renalase/ cr.)
3 5 3 3 c 10 c 25 c 50 c 75 c 90 c 97 c
Age (years) L M S −2.0001 −1.3334 −0.6667 0 0.6667 1.3334 2.0001
0–2.9 38.08 245.26 81.3 19.42 60.58 133.65 245.26 401.46 607.82 869.55
3–5.9 30.97 190.17 85.18 16.88 46.91 101.84 190.17 320.88 503.27 746.99
6–8.9 27.81 211.09 93.38 15.14 45.78 106.56 211.1 374.85 614.94 950.09
9–11.9 26.01 211.71 105.08 10.11 37.06 97.69 211.71 402.95 699.21 1132.15
12–14.9 24.12 156.33 113.71 5.79 23.68 67.68 156.33 313.62 569.13 958.2
15–17.9 21.60 99.51 120.89 3.25 13.72 41.05 99.52 209.21 396.78 696.15
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possibility that our relatively low sample size might have some
influence on this observation.
The source of urine renalase is not fully documented. Renalase
is secreted into the bloodstream, and its levels are regulated by
three key factors: renal function, renal perfusion, and catechol-
amine levels. Kidney tissue is the main source of renalase, which
is the only enzyme with a potent hydrolytic activity toward
catecholamines [5]. In renal tissue, renalase is primarily detected
in renal tubular epithelial cells, mesangial cells, and podocytes
[13].Wang et al. showed that only tubular epithelial cells secreted
renalase into supernatant, suggesting that these cells are the
primary renalase-secreting cells in the kidney [14]. Previous
studies indicated that decreased renalase concentration was asso-
ciated with increased levels of circulating catecholamines and
elevated BP [15]. In this study, we also showed a significantly
negative correlation between urine renalase/Cr and both systolic
and diastolic BP. However, we correlated BP values, not percen-
tiles, so we cannot exclude the influence of age on our results.
Nevertheless, our findings are in agreement with Wu et al. [16],
who revealed that in the renalase knockout mouse model, lack of
endogenous renalase increased sBP and dBP [16]. It was also
shown that blood renalase levels were inversely correlated with
sBP in patients with resistant hypertension [17, 18].
On the other hand, renalase was positively correlated with
dBP in patients wtih type 2 diabetes, though these observations
were focused on serum renalase concentration [19] in patients
with diabetic nephropathy, which obviously caused elevated BP.
Controversially, both renalase and BP levels were higher in
patients with a severe kidney insufficiency (serum Cr >
1.5 mg/dl).
The more surprising correlation in our study was with BMI
Z-score. No data were found in the literature regarding this
relationship; however, a possible explanation may be the
coexistence of higher BP values with higher BMI Z-score.
Future study investigating the role of renalase in obesity
would be very interesting.
Conclusion
To the best of our knowledge, this is the first study to present
reference values of urine renalase excretion in a pediatric
population. Although the study is based on a small number
of participants, it is worth noting that reference values were
determined in a group of healthy children. Further studies
should concentrate on the influence of increased BP or obesity
on urine renalase excretion in children and teenagers. The
most important limitation in this study is that we measured
urine renalase concentration using a commercially available
assay, and as renalase is an enzyme, its activity should be
measured, and assessing its expression only does not ascertain
definitively if the protein is active.
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Fig. 2 Correlation between urine
renalase/creatinine ratio and
systolic blood pressure (sBP)
(blue line) and between urine
renalase/creatinine ratio and
diastolic blood pressure (dBP)
(red line)
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